• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

145.68 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 145.68
Bid (Size) 143.29 (100)
Ask (Size) 148.75 (200)
Prev. Close 145.68
Today's Range 145.68 - 145.68
52wk Range 112.34 - 170.46
Shares Outstanding N/A
Dividend Yield 3.28%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking ↗
June 01, 2026
This little-discussed pipeline program could prove to be a big success. 
Via The Motley Fool
News headline image
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem ↗
May 27, 2026
A concentrated pharma focus sets VanEck apart from iShares’ broader healthcare approach. See how portfolio differences shape risk and income profiles. 
Via The Motley Fool
Topics ETFs

Performance

YTD
+5.2%
+5.2%
1 Month
+0.7%
+0.7%
3 Month
-12.7%
-12.7%
6 Month
+13.0%
+13.0%
1 Year
+24.8%
+24.8%

More News

Read More
News headline image
Pediatrics Medicine Market Size, Industry Report By 2035 ↗
May 22, 2026
Via Talk Markets
Topics Economy
News headline image
3 International ETFs for Investors Looking Beyond U.S. Stocks ↗
May 18, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Case for Dividend Investors ↗
April 08, 2026
Via Chartmill
News headline image
As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade ↗
May 18, 2026
Via MarketBeat
Topics Credit Cards ETFs Economy
News headline image
BioAge Labs R&D Day: BGE-102 Phase I Shows Big hs-CRP Drops, Sets Up Cardio & DME POC Trials ↗
May 08, 2026
Via MarketBeat
News headline image
PTCT Q1 2026 Earnings Transcript ↗
May 08, 2026
Via The Motley Fool
News headline image
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout ↗
May 06, 2026
Via Investor's Business Daily
News headline image
Incyte (INCY) Q2 2025 Earnings Transcript ↗
April 28, 2026
Via The Motley Fool
News headline image
Novartis Dips As Generics Take A Bite Out Of Its First-Quarter Sales ↗
April 28, 2026
Via Investor's Business Daily
News headline image
Better Pharma Dividend Stock: Novartis vs. Merck ↗
April 17, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
April 15, 2026
Via MarketMinute
Topics Economy Intellectual Property
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
April 14, 2026
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Big Pharma Deepens AI Ties. What It Means For Novo, Novartis. ↗
April 14, 2026
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)
April 13, 2026
Via Finterra
Topics Economy Initial Public Offering
News headline image
3 Low-Volatility ETFs for Peace of Mind in Turbulent Times ↗
April 13, 2026
Via MarketBeat
Topics ETFs
News headline image
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
April 06, 2026
Via MarketMinute
Topics Economy World Trade
News headline image
Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
April 03, 2026
Via MarketMinute
Topics Economy Government Lawsuit
News headline image
Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗
April 01, 2026
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗
April 01, 2026
Via The Motley Fool
News headline image
Biogen's $5.6 Billion Acquisition of Apellis: A Strategic Pivot into Rare Kidney Diseases
March 31, 2026
Via MarketMinute
News headline image
Could Investing $10,000 in VYMI Make You a Millionaire? ↗
March 30, 2026
Via The Motley Fool
Topics ETFs Stocks
News headline image
Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline ↗
March 27, 2026
Via Benzinga
News headline image
International ETFs: EEM and IEFA Offer Distinct Global ETF Choices ↗
March 27, 2026
Via The Motley Fool
Topics ETFs

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 145.68
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 06/01/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap